These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20203676)

  • 1. Devolving therapeutic pyramids.
    Hanauer SB
    Nat Rev Gastroenterol Hepatol; 2010 Mar; 7(3):119-20. PubMed ID: 20203676
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
    Wolfe F; Caplan L; Michaud K
    J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
    [No Abstract]   [Full Text] [Related]  

  • 3. Early intervention in rheumatoid arthritis.
    Vasanth LC; Paget SA
    Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.
    Murphy G; Coughlan R; Devlin J; FitzGerald O; McCarthy G
    Ir Med J; 2009 Jun; 102(6):170-2. PubMed ID: 19722351
    [No Abstract]   [Full Text] [Related]  

  • 5. In quest of the Holy Grail: efficacy versus effectiveness in rheumatoid arthritis.
    Fleischmann R
    J Rheumatol; 2002 Sep; 29(9):2018-9; author reply 2019. PubMed ID: 12233903
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatoid arthritis.
    Emery P; Foster W; Suarez-Almazor M
    Clin Evid; 2002 Jun; (7):1101-21. PubMed ID: 12230730
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature.
    Peyrin-Biroulet L
    Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rheumatoid arthritis - target-oriented treatment focussing remission].
    Fiehn C
    Dtsch Med Wochenschr; 2012 Feb; 137(5):206-9. PubMed ID: 22278692
    [No Abstract]   [Full Text] [Related]  

  • 9. Is structural damage evaluation by traditional radiographs still relevant in rheumatoid arthritis clinical trials?
    Haraoui B; Karsh J; Pope JE; Thorne JC; Keystone EC
    J Rheumatol; 2014 Nov; 41(11):2325. PubMed ID: 25362720
    [No Abstract]   [Full Text] [Related]  

  • 10. RAPID: rheumatoid arthritis.
    Weinblatt ME; Kuritzky L
    J Fam Pract; 2007 Apr; 56(4 Suppl):S1-7; quiz S8. PubMed ID: 17403322
    [No Abstract]   [Full Text] [Related]  

  • 11. A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.
    Smolen JS; Sokka T; Pincus T; Breedveld FC
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S209-10. PubMed ID: 14969080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current therapeutic strategy for rheumatoid arthritis].
    Wollenhaupt J; Alten R; Burkhardt H; Edelmann E; Gromnica-Ihle E; Krause A; Krüger K; Manger B; Lorenz H; Müller-Ladner U; Nüsslein H; Pott HG; Tony H; Schneider M
    MMW Fortschr Med; 2006 Oct; 148(42):38-42; quiz 43. PubMed ID: 17621798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy for rheumatoid arthritis].
    Sibilia J
    Ann Med Interne (Paris); 2002 Feb; 153(1):41-52. PubMed ID: 11994689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of severe synovial arthritis with drugs].
    Korpela M
    Duodecim; 2004; 120(6):707-14. PubMed ID: 15119232
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 16. [3/5 Rheumatoid arthritis].
    Blond B
    Soins; 2009 Mar; (733):57-8. PubMed ID: 19366009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current treatment of rheumatoid arthritis].
    Carli P; Landais C; Aletti M; Cournac JM; Poisnel E; Paris JF
    Rev Med Interne; 2009 Dec; 30(12):1067-79. PubMed ID: 19833415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous rash from the use of medicine for rheumatoid arthritis].
    Hannuksela M
    Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis.
    Mullan RH; Bresnihan B
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S158-64. PubMed ID: 14969069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics.
    Aletaha D; Smolen JS
    Curr Rheumatol Rep; 2003 Dec; 5(6):409-12. PubMed ID: 14609484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.